Nightstar Therapeutics to Present at the Deutsche Bank 43rd Annual Health Care Conference
April 30 2018 - 6:30AM
LEXINGTON, Mass. and LONDON, April 30, 2018 (GLOBE
NEWSWIRE) -- Nightstar Therapeutics plc (NASDAQ:NITE), a
clinical-stage gene therapy company developing treatments for rare
inherited retinal diseases, today announced that the company will
participate in the Deutsche Bank 43rd Annual
Health Care Conference on Tuesday, May 8 at 4:10 p.m. ET in Boston,
MA.
To access the live webcast, please
visit ir.nightstartx.com. A replay of the webcast will be
available on the Nightstar website for two weeks following the
conference.
About Nightstar
Nightstar is a leading clinical-stage gene therapy
company focused on developing and commercializing novel one-time
treatments for patients suffering from rare inherited retinal
diseases that would otherwise progress to blindness. Nightstar's
lead product candidate, NSR-REP1, is currently in Phase 3
development for the treatment of patients with choroideremia, a
rare, degenerative, genetic retinal disorder that has no current
treatments. Results from a Phase 1/2 trial of NSR-REP1 were
published in The Lancet in 2014 and in The New
England Journal of Medicine in 2016. Nightstar's second
product candidate, NSR-RPGR, is currently being evaluated in a
Phase 1/2 clinical trial for the treatment of patients with
X-linked retinitis pigmentosa, an inherited X-linked recessive
retinal disease.
For more information about Nightstar or its
clinical trials, please visit www.nightstartx.com.
Contacts:
Senthil Sundaram, Chief Financial Officer
Brian Luque, Sr. Manager, Investor Relations
investors@nightstartx.com
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Nightstar Therapeutics via Globenewswire
Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Historical Stock Chart
From Apr 2023 to Apr 2024